Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 3
2011 7
2012 9
2013 9
2014 5
2015 9
2016 8
2017 6
2018 6
2019 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

55 results
Results by year
Filters applied: . Clear all
Page 1
Update on Diabetic Nephropathy: Core Curriculum 2018.
Umanath K, Lewis JB. Umanath K, et al. Am J Kidney Dis. 2018 Jun;71(6):884-895. doi: 10.1053/j.ajkd.2017.10.026. Epub 2018 Feb 3. Am J Kidney Dis. 2018. PMID: 29398179 Review.
Diabetic Kidney Disease.
Tong L, Adler SG. Tong L, et al. Clin J Am Soc Nephrol. 2018 Feb 7;13(2):335-338. doi: 10.2215/CJN.04650417. Epub 2017 Oct 18. Clin J Am Soc Nephrol. 2018. PMID: 29046291 Free PMC article. No abstract available.
Rationale and protocol of the Study Of diabetic Nephropathy with AtRasentan (SONAR) trial: A clinical trial design novel to diabetic nephropathy.
Heerspink HJL, Andress DL, Bakris G, Brennan JJ, Correa-Rotter R, Dey J, Hou FF, Kitzman DW, Kohan D, Makino H, McMurray J, Perkovic V, Tobe S, Wigderson M, Parving HH, de Zeeuw D. Heerspink HJL, et al. Diabetes Obes Metab. 2018 Jun;20(6):1369-1376. doi: 10.1111/dom.13245. Epub 2018 Mar 9. Diabetes Obes Metab. 2018. PMID: 29405626 Free PMC article. Clinical Trial.
Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on All-Cause Mortality and Renal Outcomes in Patients with Diabetes and Albuminuria: a Systematic Review and Meta-Analysis.
Wang K, Hu J, Luo T, Wang Y, Yang S, Qing H, Cheng Q, Li Q. Wang K, et al. Kidney Blood Press Res. 2018;43(3):768-779. doi: 10.1159/000489913. Epub 2018 May 22. Kidney Blood Press Res. 2018. PMID: 29794446 Free article. Review.
Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).
Schutte E, Lambers Heerspink HJ, Lutgers HL, Bakker SJ, Vart P, Wolffenbuttel BH, Umanath K, Lewis JB, de Zeeuw D, Gansevoort RT. Schutte E, et al. Am J Kidney Dis. 2015 Sep;66(3):450-8. doi: 10.1053/j.ajkd.2015.03.032. Epub 2015 May 16. Am J Kidney Dis. 2015. PMID: 25987260 Clinical Trial.
BP and Renal Outcomes in Diabetic Kidney Disease: The Veterans Affairs Nephropathy in Diabetes Trial.
Leehey DJ, Zhang JH, Emanuele NV, Whaley-Connell A, Palevsky PM, Reilly RF, Guarino P, Fried LF; VA NEPHRON-D Study Group. Leehey DJ, et al. Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2159-69. doi: 10.2215/CJN.02850315. Epub 2015 Oct 19. Clin J Am Soc Nephrol. 2015. PMID: 26482258 Free PMC article. Clinical Trial.
Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
Thomopoulos C, Parati G, Zanchetti A. Thomopoulos C, et al. J Hypertens. 2017 May;35(5):922-944. doi: 10.1097/HJH.0000000000001276. J Hypertens. 2017. PMID: 28141660 Review.
55 results
Jump to page
Feedback